Advertisement

Topics

Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update

11:39 EDT 8 Aug 2017 | Biotech-Finances

Thursday, August 3rd 2017 at 8:01pm UTC Enrollment completed in Phase 3 STATUS Trial of brexanolone in SRSE; reiterate Q3 2017 guidance for top-line results Positive scientific advice from European Medicines Agency on development of brexanolone in PPD provides regulatory path in EU Updated guidance for SAGE-217 Phase 2 placebo-controlled trial in major depressive disorder; …

Cet article Sage Therapeutics Announces Second Quarter 2017 Financial Results and
Provides Pipeline Update
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update

NEXT ARTICLE

More From BioPortfolio on "Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update"

Quick Search
Advertisement